Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific production - Institute for Cancer Research
A kick-off seminar focusing on how to improve recruitment and facilitate career building within the field of health research will be held in the new research building at the Norwegian Radium Hospital at Montebello June 21st. Main target groups for the seminar are leaders and heads of research from hospital trusts, universities and colleges within South-Eastern Norway Regional Health Authority (Helse Sør-Øst). The programs represent a regional effort from Helse Sør-Øst.
Anja Nilsen (photo) from Arne Klungland's group at the Department of Microbiology, Oslo University Hospital, is shared first-author on a collaborative work entitled "ALKBH4-dependent demethylation of actin regulates actomyosin dynamics", recently published in Nature communications.
Rolf Skotheim (photo) is the site responsible in Oslo, and says that across all types of cancer, testicular cancer is now the type for which known susceptibility genes explain the largest fraction the genetic risk.
Kristian Berg at the Department of Radiation Biology at the Institute for Cancer Research played a key role in when the technique of "photochemical internalization" (PCI) was developed. This method was introduced in 1995.
The story behind PCI is widely presented in a popularized form on the web page of the Norwegian Broadcasting Corporation (NRK) as well as on the much visited Norwegian popular science web site "forskning.no".
Llorente and coworkers publish detailed lipidomic analyses of exosomes released from prostate cancer cells
Project group leader Alicia Llorente, working in the group of Kirsten Sandvig, has recently published the lipid composition of a prostate cancer cell line and of the exosomes released from these cells.
The work was performed in collaboration with two Finnish research groups and published in Biochim. Biophys. Acta (Mol. Cell Biol. Lip.; journal impact factor 5.3). The study, based on the quantification of 280 molecular lipid species, provides the most extensive lipid analysis of cells and their released exosomes to date.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of April 2013, this honor goes to Annetine Staff from the Department of Gynaecology at the Women and Childrens Division at Oslo University Hospital.
Focus on recruitment and career building in health research
May 24, 2013
May 6, 2013
Inst. for Cancer Research
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
BMC Cancer, 13 (1), 245 (in press)
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
Influence of KIR gene copy number on natural killer cell education
Blood (in press)